Atlas Trials

Trial to Evaluate the Long-term Efficacy of Oral Aripiprazole in the Treatment of Pediatric Participants With Tourette's Disorder

Clinical trial NCT03661983 · TERMINATED

Trial details

NCT number
NCT03661983
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
Tourette's Disorder (TD)
Start date
2018-10-13
Primary completion
2020-06-30
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.